These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
245 related articles for article (PubMed ID: 34233606)
1. Comparing neoadjuvant long-course chemoradiotherapy with short-course radiotherapy in rectal cancer. Wang J; Long Y; Liu K; Pei Q; Zhu H BMC Gastroenterol; 2021 Jul; 21(1):277. PubMed ID: 34233606 [TBL] [Abstract][Full Text] [Related]
2. [Analysis on efficacy and safety of total neoadjuvant therapy in patients with locally advanced rectal cancer with high risk factors]. Ouyang GL; Meng WJ; Shu P; Deng XB; Wu B; Jiang D; Zhuang H; Shen YL; Zhou ZG; Wang ZQ; Wang X Zhonghua Wei Chang Wai Ke Za Zhi; 2019 Apr; 22(4):349-356. PubMed ID: 31054549 [No Abstract] [Full Text] [Related]
3. [Comparison of short-term efficacy and perioperative safety between neoadjuvant therapy and total neoadjuvant therapy in patients with locally advanced rectal cancer]. Zhai ZW; Zhang KN; Wang C; Han JG; Ma HC; Wei GH; Yang Y; Wang ZJ Zhonghua Wei Chang Wai Ke Za Zhi; 2020 Mar; 23(3):274-280. PubMed ID: 32192307 [No Abstract] [Full Text] [Related]
4. Clinicopathological Outcomes in Patients With Locally Advanced Rectal Cancer Undergoing Preoperative Short- Kim JS; Chung MJ; Lee DY; Lee SH; Jeong SK; Yoo BE; Chung CS; Chung WK In Vivo; 2023; 37(6):2768-2775. PubMed ID: 37905618 [TBL] [Abstract][Full Text] [Related]
5. Neoadjuvant intermediate-course versus long-course chemoradiotherapy in T3-4/N0+ rectal cancer: Istanbul R-02 phase II randomized study. Senyurek S; Saglam S; Saglam EK; Yanar H; Gok K; Tastekin D; Akbas CK; Sakin ND; Kartal GD; Balik E; Keskin M; Sanli Y; Gulluoglu M; Akgun Z Oncol Res; 2023; 31(5):689-696. PubMed ID: 37547762 [TBL] [Abstract][Full Text] [Related]
6. Long-term quality-of-life after neoadjuvant short-course radiotherapy and long-course radiochemotherapy for locally advanced rectal cancer. Guckenberger M; Saur G; Wehner D; Thalheimer A; Kim M; Germer CT; Flentje M Radiother Oncol; 2013 Aug; 108(2):326-30. PubMed ID: 24021342 [TBL] [Abstract][Full Text] [Related]
7. Comparison of pathological complete response rates after neoadjuvant short-course radiotherapy or chemoradiation followed by delayed surgery in locally advanced rectal cancer. Hoendervangers S; Couwenberg AM; Intven MPW; van Grevenstein WMU; Verkooijen HM Eur J Surg Oncol; 2018 Jul; 44(7):1013-1017. PubMed ID: 29650419 [TBL] [Abstract][Full Text] [Related]
8. Development and Assessment of a Clinical Calculator for Estimating the Likelihood of Recurrence and Survival Among Patients With Locally Advanced Rectal Cancer Treated With Chemotherapy, Radiotherapy, and Surgery. Weiser MR; Chou JF; Keshinro A; Chapman WC; Bauer PS; Mutch MG; Parikh PJ; Cercek A; Saltz LB; Gollub MJ; Romesser PB; Crane CH; Shia J; Markowitz AJ; Garcia-Aguilar J; Gönen M; JAMA Netw Open; 2021 Nov; 4(11):e2133457. PubMed ID: 34748003 [TBL] [Abstract][Full Text] [Related]
9. Acute Adverse Events and Postoperative Complications in a Randomized Trial of Preoperative Short-course Radiotherapy Versus Long-course Chemoradiotherapy for T3 Adenocarcinoma of the Rectum: Trans-Tasman Radiation Oncology Group Trial (TROG 01.04). Ansari N; Solomon MJ; Fisher RJ; Mackay J; Burmeister B; Ackland S; Heriot A; Joseph D; McLachlan SA; McClure B; Ngan SY Ann Surg; 2017 May; 265(5):882-888. PubMed ID: 27631775 [TBL] [Abstract][Full Text] [Related]
10. Neoadjuvant long-course chemoradiation remains strongly favored over short-course radiotherapy by radiation oncologists in the United States. Mowery YM; Salama JK; Zafar SY; Moore HG; Willett CG; Czito BG; Hopkins MB; Palta M Cancer; 2017 Apr; 123(8):1434-1441. PubMed ID: 27984651 [TBL] [Abstract][Full Text] [Related]
11. Randomized trial of short-course radiotherapy versus long-course chemoradiation comparing rates of local recurrence in patients with T3 rectal cancer: Trans-Tasman Radiation Oncology Group trial 01.04. Ngan SY; Burmeister B; Fisher RJ; Solomon M; Goldstein D; Joseph D; Ackland SP; Schache D; McClure B; McLachlan SA; McKendrick J; Leong T; Hartopeanu C; Zalcberg J; Mackay J J Clin Oncol; 2012 Nov; 30(31):3827-33. PubMed ID: 23008301 [TBL] [Abstract][Full Text] [Related]
12. [Application of short-course radiotherapy with total neoadjuvant therapy in the treatment of middle and low rectal cancer]. Chen CJ; Yang CK; Jian JL; Guan S; Xie MM Zhonghua Yi Xue Za Zhi; 2023 Jan; 103(4):271-277. PubMed ID: 36660788 [No Abstract] [Full Text] [Related]
13. Short-course radiotherapy with consolidation chemotherapy versus conventionally fractionated long-course chemoradiotherapy for locally advanced rectal cancer: randomized clinical trial. Chakrabarti D; Rajan S; Akhtar N; Qayoom S; Gupta S; Verma M; Srivastava K; Kumar V; Bhatt MLB; Gupta R Br J Surg; 2021 May; 108(5):511-520. PubMed ID: 33724296 [TBL] [Abstract][Full Text] [Related]
14. Short course radiotherapy and delayed surgery for locally advanced rectal cancer in frail patients: is it a valid option? Lancellotti F; Solinas L; Sagnotta A; Mancini S; Cosentino LPM; Belardi A; Battaglia B; Mirri MA; Ciabattoni A; Salerno F; Loponte M Eur J Surg Oncol; 2021 Aug; 47(8):2046-2052. PubMed ID: 33757649 [TBL] [Abstract][Full Text] [Related]
15. [Efficacy analysis of neoadjuvant chemoradiotherapy combined with total pelvic exenteration in the treatment of primary T4b rectal cancer]. Wu T; Wen L; Zhang J; Wu Y; Jiang Y; Chen G; Wang X; Huang S; Wan Y Zhonghua Wei Chang Wai Ke Za Zhi; 2019 Jan; 22(1):59-65. PubMed ID: 30703795 [TBL] [Abstract][Full Text] [Related]
16. Four-week neoadjuvant intensity-modulated radiation therapy with concurrent capecitabine and oxaliplatin in locally advanced rectal cancer patients: a validation phase II trial. Arbea L; Martínez-Monge R; Díaz-González JA; Moreno M; Rodríguez J; Hernández JL; Sola JJ; Ramos LI; Subtil JC; Nuñez J; Chopitea A; Cambeiro M; Gaztañaga M; García-Foncillas J; Aristu J Int J Radiat Oncol Biol Phys; 2012 Jun; 83(2):587-93. PubMed ID: 22079731 [TBL] [Abstract][Full Text] [Related]
17. Prognostic significance of tumour regression grade after neoadjuvant chemoradiotherapy for a cohort of patients with locally advanced rectal cancer: an 8-year retrospective single-institutional study. Xu L; Cai S; Xiao T; Chen Y; Qiu H; Wu B; Lin G; Sun X; Lu J; Zhou W; Xiao Y Colorectal Dis; 2017 Jul; 19(7):O263-O271. PubMed ID: 28603932 [TBL] [Abstract][Full Text] [Related]
18. The effects of chemoradiotherapy on recurrence and survival in locally advanced rectal cancers with curative total mesorectal excision: a prospective, nonrandomized study. Akgun E; Ozkok S; Tekin M; Yoldas T; Caliskan C; Kose T; Karabulut B; Sezak M; Elmas N; Ozutemiz O World J Surg Oncol; 2017 Nov; 15(1):205. PubMed ID: 29166925 [TBL] [Abstract][Full Text] [Related]
19. [Neoadjuvant chemoradiotherapy combined with surgery versus direct surgery in the treatment of Siewert type II and III adenocarcinomas of the esophagogastric junction: long-term prognostic analysis of a prospective randomized controlled trial]. Tian Y; Wang Q; Wang J; Qiao XY; Zhang J; Lin YC; Li Y; Fan LQ; Yang PG; Zhao Q Zhonghua Wei Chang Wai Ke Za Zhi; 2021 Feb; 24(2):128-137. PubMed ID: 33508918 [No Abstract] [Full Text] [Related]
20. [Comparison of long-term efficacy between watch and wait strategy and total mesorectal excision in locally advanced rectal cancer patients with clinical complete response after neoadjuvant therapy]. Wang XH; Zhou CJ; Zhang S; Wang QX; Xiao WW; Ding PR; Chen G; Pan ZZ; Zeng ZF; Gao YH Zhonghua Wei Chang Wai Ke Za Zhi; 2020 Mar; 23(3):266-273. PubMed ID: 32192306 [No Abstract] [Full Text] [Related] [Next] [New Search]